Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Submitted by
admin
on January 27, 2012 - 3:12pm
Source:
Bloomberg
News Tags:
Amylin
FDA
Alkermes
diabetes
Bydureon
Headline:
Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Do Not Allow Advertisers to Use My Personal information
